Clinical Trial Update: Safety and Feasibility of PD-1 Blockade in the Treatment of dMMR or MSI-H Rectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and feasibility of PD-1 blockade in dMMR/MSI-H rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• PD-1 blockade

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Rectal Neoplasms | Phase 1 | Status: COMPLETED